CTRI Number |
CTRI/2023/07/054717 [Registered on: 04/07/2023] Trial Registered Prospectively |
Last Modified On: |
30/06/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda Other (Specify) [Enema] |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
A clinical study to evaluate the efficacy of kukkutanda basti in hypoalbuminemia in childhood minimal changes nephrotic syndrome. |
Scientific Title of Study
|
An open labelled controlled clinical study to evaluate the efficacy of kukkutanda basti in hypoalbuminemia in childhood minimal changes nephrotic syndrome. |
Trial Acronym |
nil |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Puza Meinam |
Designation |
PG Scholar |
Affiliation |
Parul Institute of Ayurved |
Address |
Kaumarbhritya- OPD no 103 and IPD, Parul Ayurved Hospital, Parul University, Limda, Vadodara, Gujarat-391760
Vadodara GUJARAT 391760 India |
Phone |
9035681132 |
Fax |
|
Email |
poojameinam@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dipeeka Surwase |
Designation |
Associate Professor and Head of Department, Kaumarbhritya |
Affiliation |
Parul Institute of Ayurved |
Address |
Kaumarbhritya- OPD no 103 and IPD, Parul Ayurved Hospital, Parul University, Limda, Vadodara, Gujarat-391760
Vadodara GUJARAT 391760 India |
Phone |
9860750957 |
Fax |
|
Email |
drdipeeka77@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dipeeka Surwase |
Designation |
Associate Professor and Head of Department, Kaumarbhritya |
Affiliation |
Parul Institute of Ayurved |
Address |
Kaumarbhritya- OPD no 103 and IPD, Parul Ayurved Hospital, Parul University, Limda, Vadodara, Gujarat-391760
Vadodara GUJARAT 391760 India |
Phone |
9860750957 |
Fax |
|
Email |
drdipeeka77@gmail.com |
|
Source of Monetary or Material Support
|
Kaumarbhritya-OPD no 103 and IPD, Parul Ayurved Hospital, Parul University, Limda, Vadodara, Gujarat, Pin no- 391760 |
|
Primary Sponsor
|
Name |
Parul Ayurved Hospital |
Address |
Kaumarbhritya-OPD no 103 and IPD, Parul Ayurved Hospital, Parul University, Limda, Vadodara, Gujarat, Pin no- 391760 |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Puza Meinam |
Parul Ayurved Hospital |
Kaumarbhritya- OPD no 103 and IPD, Parul Ayurved Hospital, Parul University, Limda, Vadodara, 391760 Vadodara GUJARAT |
9035681132
poojameinam@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
INSTITUTIONAL ETHICS COMMITTEE FOR HUMAN RESEARCH |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:N040||Nephrotic syndrome with minor glomerular abnormality. Ayurveda Condition: MUTRAVAHASROTOVIKARAH, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Comparator Arm (Non Ayurveda) | | - | Medical treatment | Medical treatment without basti | 2 | Intervention Arm | Procedure | - | bastikarma/vastikarma, बसà¥à¤¤à¤¿à¤•रà¥à¤®/वसà¥à¤¤à¤¿à¤•रà¥à¤® | (Procedure Reference: Charaka samhita sidhi sthana 3rd chapter, Procedure details: Prepared basti dravya will be injected through rectal route with the help of red rubber cathetor & 25-50 ml syringe. Patient will be advised for left lateral position for next 30 mins.Gently tapping of hips will be done in every patients.) (1) Medicine Name: Egg albumin, Reference: Other than classical, Route: Rectal, Dosage Form: Not Applicable, Dose: 30(ml), Frequency: od, Duration: 7 Days |
|
|
Inclusion Criteria
|
Age From |
3.00 Year(s) |
Age To |
10.00 Year(s) |
Gender |
Both |
Details |
Age group- 3 to 10 years
Diagnosed cases of primary type of nephrotic syndrome (idiopathic) of either the
gender.
The other alternate modern treatment to be continued as per recommended dose
according to allopathy treatment protocol as per the guideline
Children with parents who agree to participate and sign informed consent |
|
ExclusionCriteria |
Details |
Patients of nephrotic syndrome due to other disorders i.e SLE, drug toxicity, any
genetic disorders.
Patients of nephrotic syndrome associated with illness like cardiovascular disease, tuberculosis, immuno deficiency syndrome, etc.
Advanced or critical phase of nephrotic syndrome which requires immediate intervention like dialysis depending on history and general condition at the point of examination as found by the investigator will be excluded from the study. |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
To manage hypoalbuminemia through rectal route without overloading proteins |
14 DAYS |
|
Secondary Outcome
|
Outcome |
TimePoints |
Relief in post hypoalbuminemia symptoms i.e
1.Secondary oedema
2.Anorexia |
21 days |
|
Target Sample Size
|
Total Sample Size="24" Sample Size from India="24"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2/ Phase 3 |
Date of First Enrollment (India)
|
19/07/2023 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Introduction Nephrotic syndrome is primarily a pediatric disorder and is 1.5 times more common in children than adults. The incidence is 2-3/100,000 children per year and majority of affected children will have steroid-sensitive minimal change disease. The characteristic features are heavy proteinurea >3-4+ /24 hr, hypoalbuminemia <2.5g/dl, edema and hyperlipidemia are often associated. Etiology: - approximately 90% of children with nephrotic syndrome have idiopathic causes. Divided into 2 groups in children 1) MCNS (High proteinuria) and 2) Nephrotic syndrome with significance lesions (low proteinuria) MCNS protein urea pathophysiology: - Undefined mechanisms alter the permeability of the glomerular filter, resulting in massive proteinuria. Primary abnormality of the epithelial foot process (podocytes) A loss of negatively charge glycoproteins within the glomerular capillary wall.
MCNS Oedema Pathophysiology Resultant fall in plasma oncotic pressure leads to interstitial edema and hypovolemia, stimulates the renin-angiotensin aldosterone axis and antidiuretics hormone secretion enhances Na and H2O retention.
Investigation shows 3-4+ g/dl proteinuria ,Serum albumin low below 2.5g/dl, serum cholesterol and triglycerides level are elevated Blood urea and creatinine within normal level except when hypovolemia and fall in renal perfusion.
AIMS: - To
study the efficacy of the kukkutanda basti in hypoalbuminemia of childhood minimal
changes nephrotic syndrome. OBJECTIVE: -Prevention
of complications due to hypoalbuminemia.
To study the role of Kukkutanda Basti
in arresting or prevent the complication during the progression of childhood
NS. :
Prevention
of complications due to hypoalbuminemia.
To study the role of Kukkutanda Basti
in arresting or prevent the complication during the progression of childhood
NS. |